Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
- I. Tannock, R. de Wit, M. Eisenberger
- MedicineThe New England journal of medicine
- 7 October 2004
TLDR
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group.
- H. Scher, S. Halabi, M. Hussain
- Medicine, BiologyJournal of clinical oncology : official journal…
- 1 March 2008
TLDR
Measuring health-related quality of life.
- D. Osoba, I. Tannock
- MedicineJournal of clinical oncology : official journal…
- 1 July 1999
Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
- A. Templeton, M. McNamara, E. Amir
- MedicineJournal of the National Cancer Institute
- 1 June 2014
TLDR
Drug penetration in solid tumours
- A. Minchinton, I. Tannock
- Biology, MedicineNature Reviews Cancer
- 1 August 2006
TLDR
Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.
- I. Tannock, D. Osoba, K. Murphy
- MedicineJournal of clinical oncology : official journal…
- 1 June 1996
TLDR
Drug resistance and the solid tumor microenvironment.
- O. Trédan, C. Galmarini, Krupa J. Patel, I. Tannock
- BiologyJournal of the National Cancer Institute
- 3 October 2007
TLDR
Acid pH in tumors and its potential for therapeutic exploitation.
- I. Tannock, D. Rotin
- BiologyCancer research
- 15 August 1989
TLDR
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study.
- D. Berthold, G. Pond, F. Soban, R. de Wit, M. Eisenberger, I. Tannock
- MedicineJournal of clinical oncology : official journal…
- 10 January 2008
TLDR
Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
- H. Fan, N. Houédé-Tchen, I. Tannock
- Medicine, PsychologyJournal of clinical oncology : official journal…
- 1 November 2005
TLDR
...
...